Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07311044

CVD/PH and Voice Characteristics

The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pulmonary Hypertension Cardiovascular Diseases Hypertension Hypertension, Pulmonary Lung Diseases Respiratory Tract Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location status: Recruiting

Location contact

Amir Lerman, MD

PRINCIPAL_INVESTIGATOR

Diana Albers

CONTACT

[email protected]

507-255-6884

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All individuals who present for a routine elective, clinically indicated, diagnostic echocardiogram at the echocardiography laboratory at Mayo Clinic
  • All individuals who have had a clinically indicated, diagnostic echocardiogram at the echocardiography lab at Mayo Clinic before a scheduled procedure in the cardiac catheterization lab at Mayo Clinic
  • All individuals who have had a clinically indicated diagnostic echocardiogram at the echocardiography lab at Mayo Clinic and have an appointment in any CV outpatient clinic.

Exclusion criteria

  • Known history of voice disorder either primary or secondary to neuromuscular or other pathology
  • Patients under the age of 18 years

Treatment and study plan

Primary outcomes

  1. Number of confirmed pulmonary hypertension diagnoses based on voice recording analysis

    Time frame: Baseline

    A successful diagnosis of pulmonary hypertension will be confirmed by echocardiogram.

Study contacts

Contact information is provided by the study sponsor or research team.

Amir Lerman, M.D.

CONTACT

[email protected]

Diana Albers

CONTACT

[email protected]

507-255-6884

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Cardiovascular Disease/ Pulmonary Hypertension and Voice Characteristics Study

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Dec 30, 2025
Registry last updated
Dec 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.